Newland Pharmaceutical Co., Ltd. (SHE:301277)

Newland Pharmaceutical Revenue

Newland Pharmaceutical had revenue of 206.95M CNY in the quarter ending March 31, 2026, a decrease of -5.84%. This brings the company's revenue in the last twelve months to 659.54M, down -13.41% year-over-year. In the year 2025, Newland Pharmaceutical had annual revenue of 672.38M, down -7.44%.

• Revenue (ttm): 659.54M
• Revenue Growth: -13.41%
• P/S Ratio: 5.46
• Revenue / Employee: 672.31K
• Employees: 981
• Market Cap: 3.60B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	672.38M	-54.06M	-7.44%
Dec 31, 2024	726.44M	75.00M	11.51%
Dec 31, 2023	651.44M	24.07M	3.84%
Jan 1, 2023	627.36M	113.53M	22.09%
Jan 1, 2022	513.84M	80.71M	18.64%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 11, 2026

Data Sources Report a data error